Arguably, while some report that the high incidence may be due to over-diagnosis of prostate cancer and voice caution regarding the benefit of protein-specific antigen screening (PSA) [11], the mortality rate for prostate cancer still varies proportionally with increase in age, with 55% of prostate cancer deaths occurring in men over 65 [2]. This evidence concerns the gene KLK3 and prostate carcinoma.